{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:24:58Z","timestamp":1778876698573,"version":"3.51.4"},"reference-count":13,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"unspecified","delay-in-days":170,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R61\/R33HL139852"],"award-info":[{"award-number":["R61\/R33HL139852"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1100377"],"award-info":[{"award-number":["APP1100377"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001422"],"award-info":[{"award-number":["UL1TR001422"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2025,11,23]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertension is a major cause of premature death worldwide, controlled by only one in five adults. Two trials (Australia and USA) found a single quadpill containing a quarter dosage of four classes of medication effective in reducing blood pressure (BP) among participants with hypertension. By pooling these trials, we can estimate the overall benefit of the quadpill and its heterogeneity across subgroups and two important barriers for BP control: clinician medication inertia and participant medication adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In a prespecified pooled individual participant data analysis of two QUARTET randomised, multicentre, double-blinded trials in people with hypertension using \u22641medication, quadpill (irbesartan (37.5\u2009mg) (Australia)\/candesartan (2\u2009mg) (USA)), amlodipine (1.25\u2009mg), indapamide (0.625\u2009mg), bisoprolol (2.5\u2009mg) unattended office systolic BP (SBP) at 12\u2009weeks was compared with initial monotherapy (irbesartan (150\u2009mg) (Australia), candesartan (8\u2009mg) (USA)). Heterogeneity was assessed using an interaction term in the mixed cox model. Adherence, \u226580%\u2009pill count and treatment inertia were estimated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In 653 participants (Australia, 591 (91%); USA, 62 (9%)) a significant drop in mean SBP (6.5\u2009mm Hg (95% CI 4.8 to 8.8; p&lt;0\u00b7001)) and diastolic BP (5.6\u2009mm Hg (95% CI 4.5 to 6.9; p&lt;0.001)) in favour of the quadpill was found, with less need for uptitration (p&lt;0.001) and less treatment inertia (non-significant: p=0.303). Adherence was high for both treatment arms (over 80%). Compared with monotherapy, the quadpill effect varied by ethnicity (SBP reduced by White (6.9\u2009mm Hg; 95% CI 4.7 to 9.2), Hispanic (3.3\u2009mm Hg; 95% CI 4.0 to 10.6), Asian (12.3\u2009mm Hg; 95% CI 6.2 to 18.5) and Black\/other (1.4\u2009mm Hg; 95% CI \u22129.0 to 6.3), interaction p=0.032).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This prospective individual participant data pooled analysis provides further evidence that the quadpill strategy is superior to initial monotherapy by virtue of improved BP-lowering, less need for uptitration and being associated with less treatment inertia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2025-003843","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T04:10:28Z","timestamp":1766117428000},"page":"e003843","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Pooled randomised QUARTET trials assessing effectiveness of a single pill for hypertension"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5484-9144","authenticated-orcid":false,"given":"Simone","family":"Marschner","sequence":"first","affiliation":[{"name":"Westmead Applied Research Centre, The University of Sydney, Westmead, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7412-2519","authenticated-orcid":false,"given":"Mark D","family":"Huffman","sequence":"additional","affiliation":[{"name":"Cardiovascular Division and Global Health Center, Washington University in St Louis, St. Louis, Missouri, USA"},{"name":"Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Evanston, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desi","family":"quintans","sequence":"additional","affiliation":[{"name":"The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody","family":"Ciolino","sequence":"additional","affiliation":[{"name":"Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"},{"name":"Northwestern University Data Analysis and Coordinating Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1573-0554","authenticated-orcid":false,"given":"Abigail","family":"Baldridge","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Lazar","sequence":"additional","affiliation":[{"name":"Access Community Health Network, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2522-3510","authenticated-orcid":false,"given":"Emily R","family":"Atkins","sequence":"additional","affiliation":[{"name":"Health Systems Science, The George Institute for Global Health, Newtown, New South Wales, Australia"},{"name":"UNSW, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2417-4673","authenticated-orcid":false,"given":"Graham S","family":"Hillis","sequence":"additional","affiliation":[{"name":"Royal Perth Hospital and Medical School, The University of Western Australia, Perth, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9941-7161","authenticated-orcid":false,"given":"Mark R","family":"Nelson","sequence":"additional","affiliation":[{"name":"Discipline of General Practice, University of Tasmania Menzies Institute for Medical Research, Hobart, Tasmania, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-0195","authenticated-orcid":false,"given":"Markus","family":"Schlaich","sequence":"additional","affiliation":[{"name":"Dobney Hypertension Centre, The University of Western Australia, Perth, Australia"},{"name":"Royal Perth Hospital, Royal Perth Hospital, Perth, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Rodgers","sequence":"additional","affiliation":[{"name":"Cardiovascular, The George Institute for Global Health, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4693-0038","authenticated-orcid":false,"given":"Clara K","family":"Chow","sequence":"additional","affiliation":[{"name":"Westmead Applied Research Centre, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"2025121820102189000_12.2.e003843.1","unstructured":"World Health Organization (WHO) . Hypertension. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hypertension [Accessed 5 Jun 2025]."},{"key":"2025121820102189000_12.2.e003843.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2008.08329.x"},{"key":"2025121820102189000_12.2.e003843.3","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(21)01922-X","article-title":"Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial","volume":"398","author":"Chow","year":"2021","journal-title":"The Lancet"},{"key":"2025121820102189000_12.2.e003843.4","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41440-024-01658-y","article-title":"Efficacy and safety of a four-drug, quarter-dose treatment for hypertension: the QUARTET USA randomized trial","volume":"47","author":"Huffman","year":"2024","journal-title":"Hypertens Res"},{"key":"2025121820102189000_12.2.e003843.5","unstructured":"R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria; 2024. Available: https:\/\/www.R-project.org [Accessed 26 Mar 2025]."},{"key":"2025121820102189000_12.2.e003843.6","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.095497"},{"key":"2025121820102189000_12.2.e003843.7","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjr.0000170264.84820.8e"},{"key":"2025121820102189000_12.2.e003843.8","first-page":"653","article-title":"Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region","volume":"22","author":"Rodgers","year":"2004","journal-title":"J Hypertens (Los Angel)"},{"key":"2025121820102189000_12.2.e003843.9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jch.14440","article-title":"Seven\u2010action approaches for the management of hypertension in Asia \u2013 The HOPE Asia network","volume":"24","author":"Kario","year":"2022","journal-title":"J of Clinical Hypertension"},{"key":"2025121820102189000_12.2.e003843.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.08.051"},{"key":"2025121820102189000_12.2.e003843.11","first-page":"1087","article-title":"Therapeutic Inertia With Initial Low-Dose Quadruple Combination Therapy for Hypertension: Results From the QUARTET Trial","volume":"81","author":"Wang","year":"1979","journal-title":"Hypertension"},{"key":"2025121820102189000_12.2.e003843.12","doi-asserted-by":"crossref","DOI":"10.1111\/jch.14950","article-title":"Effectiveness and Safety of Using Standardized Treatment Protocols for Hypertension Compared to Usual Care: A Meta\u2010Analysis of Randomized Clinical Trials","volume":"27","author":"Satheesh","year":"2025","journal-title":"J of Clinical Hypertension"},{"key":"2025121820102189000_12.2.e003843.13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41371-024-00915-4","article-title":"Participants\u2019 views of ultra-low dose combination therapy for high blood pressure: a mixed-methods study from the QUARTET trial","volume":"38","author":"Kovoor","year":"2024","journal-title":"J Hum Hypertens"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2025-003843","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T04:10:31Z","timestamp":1766117431000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2025-003843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,12,18]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/openhrt-2025-003843"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2025-003843","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}